Wednesday, March 12th, 2014
Josh Hardy, the 7-year-old Memphis boy whose story of being denied a potentially life-saving drug has raced across the Internet, will receive the experimental medication his family and doctors hope will save his life, news sources are reporting. The boy is suffering from a rare form of kidney cancer, and is reportedly in both kidney and heart failure. More from CNN.com:
Add a Comment
The Chimerix pharmaceutical company said Tuesday that the ailing 7-year-old will receive medicine that doctors hope will help him when he becomes the first patient in a new trial set to start Wednesday.
Todd Hardy, Josh’s father, said he got the call from Chimerix president Kenneth Moch about a half hour before the public announcement was made.
“It was wonderful,” Hardy said. “Truly wonderful. It was overwhelming.”
In an emotional Facebook post, mother Aimee Hardy praised the company’s decision.
“Glory to GOD!” she wrote. “They are releasing the drug for Josh!!!!!!!!!”
The company had previously denied calls from the 7-year-old’s family to give him the drug, brincidofovir, arguing that spending the time to help Josh and others like him would slow down efforts to get the drug on the market.
Josh’s story drew national attention as his parents and supporters pushed the company to change its mind in online and media campaigns.